“…Stem cells are promising candidates for the treatment of stroke, multiple sclerosis, Huntingtonâs disease, Parkinsonâs disease, Alzheimerâs disease, amyotrophic lateral sclerosis and epilepsy, among others [ 383 , 503 , 504 , 505 ]. As with all cell-based therapies, the application of IONP-labeled cells, are helpful to monitor safety, delivery, fate and therapeutic potential of the applied cells for regeneration of injured brain tissue [ 506 , 507 , 508 , 509 , 510 , 511 , 512 , 513 , 514 , 515 , 516 , 517 , 518 , 519 , 520 , 521 ].…”